The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of often chemically unrelated compounds with some common therapeutic actions and side effects. They have potent anti-inflammatory, analgesic and antipyretic activity, and are among the most widely used drugs worldwide. It is generally thought that one of their main mechanisms of action is the inhibition of cyclo-oxygenase (COX), the enzyme responsible for biosynthesing the prostaglandins and thromboxane. NSAIDs are also associated with an increased risk of adverse gastrointestinal, renal and cardiovascular effects. This review describes the clinical pharmacology of NSAIDs, their classification, molecular mechanisms of action and adverse effects, including their possible contribution to neuro-inflammation and carcinogenesis, as well as some recent developments aimed at designing effective anti-inflammatory agents with improved safety and tolerability profiles. Keywords: NSAIDs, cyclo-oxygenases, prostanoids, adverse effects, cancer, neuro-inflammation, safe NSAIDs, Non-Steroidal Anti-Inflammatory Drugs, selective COX-2 inhibitors , COXIBs, COX-1 , COX-2 , enzyme catalysis , cytoprotection, Hydrogen sulfide-releasing non-steroidal anti-inflammatory, Nitric oxide-releasing non-steroidal anti-inflammatory
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497 · cited 2×
“A more recent study of the long-term risk of death due to cancer following randomised controlled trials of daily aspirin found a significantly reduced risk in the treatment groups; the benefit was not associated with dose, but increased with age [84].”
BackgroundKearney, P. M., Baigent, C., Godwin, J., Halls, H., Emberson, J. R., & Patrono, C. (2006) · BMJ · doi:10.1136/bmj.332.7553.1302 · Cited by 1,445
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351 · cited 1×
“It has also been found that the long- term incidence and mortality rate due to colorectal cancer is significantly reduced when at least 75 mg of aspirin are taken daily for several years [87].”
BackgroundMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Clinical trial of indomethacin in Alzheimer's disease
Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1609 · Cited by 999
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Celecoxib for the Prevention of Colorectal Adenomatous Polyps
Arber, N., Eagle, C. J., Spicak, J., Rácz, I., Dite, P., Hajer, J., Zavoral, M., Lechuga, M. J., Gerletti, P., Tang, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061652 · Cited by 975
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 827
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781
Hernández-Díaz, S., & Rodríguez, L. A. G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2093 · Cited by 716
Cuzick, J., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J., La Vecchia, C., Meyskens, F., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 714
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2
Wallace, J. L., McKnight, W., Reuter, B. K., & Vergnolle, N. (2000) · Gastroenterology · doi:10.1053/gast.2000.16510 · Cited by 705
Schnitzer, T. J., Burmester, G. R., Mysler, E., Hochberg, M. C., Doherty, M., Ehrsam, E., Gitton, X., Krammer, G., Mellein, B., Matchaba, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16893-1 · Cited by 701
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target
Samuelsson, B., Morgenstern, R., & Jakobsson, P.-J. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.1 · Cited by 538
Protective effects of NSAIDs on the development of Alzheimer disease
Vlad, S. C., Miller, D. R., Kowall, N. W., & Felson, D. T. (2008) · Neurology · doi:10.1212/01.wnl.0000311269.57716.63 · Cited by 535
Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518
Grösch, S., Tegeder, I., Niederberger, E., Bräutigam, L., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0299fje · Cited by 501
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Chen, H., Jacobs, E., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Annals of Neurology · doi:10.1002/ana.20682 · Cited by 472
Inflammatory Neurodegeneration Mediated by Nitric Oxide, Glutamate, and Mitochondria
Brown, G. C., & Bal-Price, A. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:325 · Cited by 461
Bjordal, J. M., Ljunggren, A. E., Klovning, A., & Slørdal, L. (2004) · BMJ · doi:10.1136/bmj.38273.626655.63 · Cited by 454
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
Charlier, C., & Michaux, C. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00115-6 · Cited by 432
Farrow, D. C., Vaughan, T. L., Hansten, P. D., et al. (1998) · PubMed · Cited by 416
Nitric oxide in mucosal defense: A little goes a long way
Wallace, J. L., & Miller, M. J. S. (2000) · Gastroenterology · doi:10.1053/gast.2000.9304 · Cited by 409
Harris, R., Beebe-Donk, J., Doss, H., & Doss, D. (2005) · Oncology Reports · doi:10.3892/or.13.4.559 · Cited by 408
Choi, S.-H., Aid, S., & Bosetti, F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.01.002 · Cited by 402
Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors
Grösch, S., Maier, T. J., Schiffmann, S., & Geisslinger, G. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj206 · Cited by 400
Rofecoxib: No effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled study
Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B. A., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 385
The Emerging Roles of Hydrogen Sulfide in the Gastrointestinal Tract and Liver
Fiorucci, S., Distrutti, E., Cirino, G., & Wallace, J. L. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.033 · Cited by 374
Adderley, S. R., & Fitzgerald, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5038 · Cited by 371
Chen, Y., Jobanputra, P., Barton, P., Bryan, S., Fry-Smith, A., Harris, G., & Taylor, R. (2008) · Health Technology Assessment · doi:10.3310/hta12110 · Cited by 339
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Cheng, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27540 · Cited by 339
Zhang, J., Ding, E. L., & Song, Y. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60015 · Cited by 332
Use of ibuprofen and risk of Parkinson disease
Gao, X., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31820f2d79 · Cited by 321
García Rodríguez, L. A., Tacconelli, S., & Patrignani, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.041 · Cited by 305
Calabrese, V., Bates, T. E., & Stella, A. M. G. (2000) · Neurochemical Research · doi:10.1023/a:1007604414773 · Cited by 284
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
Wallace, J. L., Caliendo, G., Santagada, V., Cirino, G., & Fiorucci, S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.042 · Cited by 271
García Rodríguez, L. A., & Barreales Tolosa, L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.007 · Cited by 249
Cytokines in Neuroinflammation and Alzheimers Disease
Cacquevel, M., Lebeurrier, N., Cheenne, S., & Vivien, D. (2004) · Current Drug Targets · doi:10.2174/1389450043345308 · Cited by 245
Wilcox, C. M., Cryer, B., & Triadafilopoulos, G. (2005) · PubMed · Cited by 239
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Esposito, E., Di Matteo, V., Benigno, A., Pierucci, M., Crescimanno, G., & Di Giovanni, G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.008 · Cited by 234
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.161 · Cited by 233
Stress-induced neuroinflammation: mechanisms and new pharmacological targets
Munhoz, C. D., García-Bueno, B., Madrigal, J. L. M., Lepsch, L. B., Scavone, C., & Leza, J. C. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008001200001 · Cited by 230
The mode of action of aspirin and similar compounds
Vane, J. R. (1976) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(76)90181-0 · Cited by 229
Fiorucci, S., Santucci, L., Gresele, P., Faccino, R. M., del Soldato, P., & Morelli, A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50096 · Cited by 224
Glial activation in Alzheimer's disease: the role of Aβ and its associated proteins
Meda, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00307-4 · Cited by 222
Loftin, C. D., Trivedi, D. B., Tiano, H. F., Clark, J. A., Lee, C. A., Epstein, J. A., Morham, S. G., Breyer, M. D., Nguyen, M., Hawkins, B. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1059 · Cited by 219
Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis
Takkouche, B., Regueira-Mendez, C., & Etminan, M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn324 · Cited by 215
Hypoxic Regulation of Angiopoietin-2 Expression in Endothelial Cells
Pichiule, P., Chavez, J. C., & LaManna, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305146200 · Cited by 210
Kraemer, S. A., Meade, E. A., & DeWitt, D. L. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90411-o · Cited by 208
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
Wang, M., Zukas, A. M., Hui, Y., Ricciotti, E., Puré, E., & FitzGerald, G. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606586103 · Cited by 205
Non‐Steroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction
Hernández‐Díaz, S., Varas‐Lorenzo, C., & García Rodríguez, L. A. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_302.x · Cited by 201
Townsend, K. P., & Praticò, D. (2005) · The FASEB Journal · doi:10.1096/fj.04-3620rev · Cited by 196
Wilms, H., Zecca, L., Rosenstiel, P., Sievers, J., Deuschl, G., & Lucius, R. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780858429 · Cited by 195
Keeble, J. E., & Moore, P. K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704876 · Cited by 187
NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects
DAVIES, N. M., RØSETH, A. G., APPLEYARD, C. B., MCKNIGHT, W., DEL SOLDATO, P., CALIGNANO, A., CIRINO, G., & WALLACE, J. L. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.115286000.x · Cited by 185
Jacobs, E. J., Rodriguez, C., Mondul, A. M., Connell, C. J., Henley, S. J., Calle, E. E., & Thun, M. J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji173 · Cited by 185
Abnet, C. C., Freedman, N. D., Kamangar, F., Leitzmann, M. F., Hollenbeck, A. R., & Schatzkin, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604880 · Cited by 181
Baraldi, P. G., Preti, D., Materazzi, S., & Geppetti, P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100062h · Cited by 176
Randomized pilot study of nimesulide treatment in Alzheimer’s disease
Aisen, P. S., Schmeidler, J., & Pasinetti, G. M. (2002) · Neurology · doi:10.1212/wnl.58.7.1050 · Cited by 176
Pasqualetti, P., Bonomini, C., Dal Forno, G., Paulon, L., Sinforiani, E., Marra, C., Zanetti, O., & Maria Rossini, P. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03325217 · Cited by 172
Human Microsomal Prostaglandin E Synthase-1
Thorén, S., Weinander, R., Saha, S., Jegerschöld, C., Pettersson, P. L., Samuelsson, B., Hebert, H., Hamberg, M., Morgenstern, R., & Jakobsson, P.-J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303227200 · Cited by 167
Zhu, J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.23.1745 · Cited by 166
The therapeutic potential of NO‐NSAIDs
Wallace, J. L., & Soldato, P. D. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00125.x · Cited by 162
Samii, A., Etminan, M., Wiens, M. O., & Jafari, S. (2009) · Drugs & Aging · doi:10.2165/11316780-000000000-00000 · Cited by 161
Feng, Z.-H., Wang, T.-G., Li, D.-D., Fung, P., Wilson, B. C., Liu, B., Ali, S. F., Langenbach, R., & Hong, J.-S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00704-8 · Cited by 160
Raynauld, J.-P., Martel-Pelletier, J., Bias, P., Laufer, S., Haraoui, B., Choquette, D., Beaulieu, A. D., Abram, F., Dorais, M., Vignon, É., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.088732 · Cited by 160
de Jong, D., Jansen, R. W. M. M., Hoefnagels, W. H. L., Mj, J.-E., Verbeek, M. M., Borm, G. F., & Kremer, B. P. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001475 · Cited by 159
Xu, D., Rowland, S. E., Clark, P., Giroux, A., Côté, B., Guiral, S., Salem, M., Ducharme, Y., Friesen, R. W., Méthot, N., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138776 · Cited by 159
Post-Training Cyclooxygenase-2 (COX-2) Inhibition Impairs Memory ConsolidationPreprint
Teather, L. A., Packard, M. G., & Bazan, N. G. (2002) · Learning & Memory · doi:10.1101/lm.43602 · Cited by 159
Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease
Soininen, H. S., West, C. R., Robbins, J. L., & Niculescu, L. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000096588 · Cited by 144
Wang, M., Lee, E., Song, W., Ricciotti, E., Rader, D. J., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2008) · Circulation · doi:10.1161/circulationaha.107.731398 · Cited by 142
NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action
Husain, S. S., Szabó, I., & Tarnawski, A. S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05528.x · Cited by 139
Cyclooxygenase-1 and -2 in the Different Stages of Alzheimers Disease Pathology
Hoozemans, J., Rozemuller, J., van Haastert, E., Veerhuis, R., & Eikelenboom, P. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480171 · Cited by 137
Chattopadhyay, M., Kodela, R., Olson, K. R., & Kashfi, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.051 · Cited by 127
Lukiw, W. J., Ottlecz, A., Lambrou, G. Ι., Grueninger, M., Finley, J., Thompson, H. W., & Bazan, N. G. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0655 · Cited by 122
Constitutive Cyclooxygenase-2 Expression in Healthy Human and Rabbit Gastric Mucosa
Zimmermann, K. C., Sarbia, M., Schrör, K., & Weber, A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.536 · Cited by 121
COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.
Hoffmann, C. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374282 · Cited by 120
McGeer, P. L. (2000) · Drugs & Aging · doi:10.2165/00002512-200017010-00001 · Cited by 118
Hermann, M., Camici, G. G., Fratton, A., Hürlimann, D., Tanner, F. C., Hellermann, J. P., Fiedler, M., Thiery, J., Neidhart, M., Gay, R. E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101683.30157.0b · Cited by 118
Rodríguez-Burford, C., Barnes, M. N., Oelschlager, D. K., Myers, R. B., Talley, L. I., Partridge, E. E., & Grizzle, W. E. (2002) · PubMed · Cited by 116
MPP + ‐induced COX‐2 activation and subsequent dopaminergic neurodegeneration
Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R. I., Lee, C., Wilson, B. C., Reece, J. M., Miller, D. S., & Hong, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2457fje · Cited by 114
Taubert, K. A., Antman, E. M., BENNETT, J. S., Daugherty, A., Furberg, C. D., & Roberts, H. R. (2007) · Cited by 112
Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease
Yermakova, A., & O'Banion, M. K. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00303-7 · Cited by 109
Nitric Oxide‐Releasing Drugs: A Novel Class of Effective and Safe Therapeutic Agents
Burgaud, J., Ongini, E., & Soldato, P. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04080.x · Cited by 109
Popolo, A. D., Memoli, A., Apicella, A., Tuccillo, C., Palma, A. M. D., Ricchi, P., Acquaviva, A. M., & Zarrilli, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203952 · Cited by 105
Therapeutic Targets in Prostaglandin E2 Signaling for Neurologic Disease
Cimino, P. J., Keene, C. D., BREYER, R. M., Montine, K. S., & Montine, T. J. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132915 · Cited by 99
Hawkey, C. J., Jones, J. I., Atherton, C. T., Skelly, M. M., Bebb, J. R., Fagerholm, U., Jonzon, B., Karlsson, P., & Bjarnason, I. (2003) · Gut · doi:10.1136/gut.52.11.1537 · Cited by 98
Tamura, M., Sebastian, S., Gürateş, B., Yang, S., Fang, Z., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8796 · Cited by 89
Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats
Rall, J., Mach, S. A., & Dash, P. K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02248-0 · Cited by 87
Ukawa, H., Yamakuni, H., Kato, S., & Takeuchi, K. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018846912032 · Cited by 85
Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E2 synthase‐1
Koeberle, A., Pollastro, F., Northoff, H., & Werz, O. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00070.x · Cited by 84
酒井, 秀., Suzuki, T., Takahashi, Y. K., Ukai, M., Tauchi, K., Fujii, T., Horikawa, N., Minamimura, T., Tabuchi, Y., Morii, M., et al. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.007 · Cited by 83
Cloning and Characterization of Cyclooxygenase-1b (Putative Cyclooxygenase-3) in Rat
Snipes, J. A., Kis, B., Shelness, G. S., Hewett, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079533 · Cited by 82
Murphy, J. F., & Fitzgerald, D. J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0757fje · Cited by 76
Cowley, T. R., Fahey, B., & O’Mara, S. M. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06251.x · Cited by 76
Selective COX‐2 inhibitors and human inflammatory bowel disease
Mccartney, Mitchell, Fairclough, et al. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00585.x · Cited by 74
Zerbini, L. F., Tamura, R. E., Correa, R. G., Czibere, A. G., Cordeiro, J., Bhasin, M., Simabuco, F. M., Wang, Y., Gu, X., Li, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024285 · Cited by 66
Small, G. W., Siddarth, P., Silverman, D. H. S., Ercoli, L. M., Miller, K. J., Lavretsky, H., Bookheimer, S. Y., Huang, S.-C., Barrio, J. R., & Phelps, M. E. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31818cd3a4 · Cited by 64
Slatore, C. G., Au, D. H., Littman, A. J., Satia, J. A., & White, E. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1110 · Cited by 64
Sharifzadeh, M. S., Naghdi, N., Khosrovani, S., Ostad, S. N., Sharifzadeh, K., & Roghani, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.041 · Cited by 61
Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity
Wernli, K. J., Newcomb, P. A., Hampton, J. M., Trentham‐Dietz, A., & Egan, K. M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604392 · Cited by 58
Fecker, L. F., Stockfleth, E., Braun, F., Rodust, P. M., Schwarz, C., Köhler, A., Leverkus, M., & Eberle, J. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.40 · Cited by 56
The Management of Hyperkalemia in Patients with Cardiovascular Disease
Khanna, A., & White, W. B. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.10.028 · Cited by 52
FDA Focuses on Drugs and Liver Damage
Kuehn, B. M. (2009) · JAMA · doi:10.1001/jama.2009.1019 · Cited by 48
Fujimi, K., Noda, K., Sasaki, K., Wakisaka, Y., Tanizaki, Y., Iida, M., Kiyohara, Y., Kanba, S., & Iwaki, T. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000101957 · Cited by 47
Fiorucci, S., & Distrutti, E. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796642508 · Cited by 46
Cyclooxygenase‐2 and Tumor Biology
Kanaoka, S., Takai, T., & Yoshida, K. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)43002-x · Cited by 45
Nonsteroidal Anti-inflammatory Drugs Suppress Glioma via 15-Hydroxyprostaglandin Dehydrogenase
Wakimoto, N., Wolf, I., Yin, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5675 · Cited by 45
Waldstein, S. R., Wendell, C. R., Seliger, S. L., Ferrucci, L., Metter, E. J., & Zonderman, A. B. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02618.x · Cited by 44
Capone, M. L., Tacconelli, S., Rodríguez, L. G., & Patrignani, P. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70310-8 · Cited by 44
Predisposition to Colorectal Cancer in Rats with Resolved Colitis
Zamunér, S. R., Bak, A., Devchand, P. R., & Wallace, J. L. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61216-3 · Cited by 41
Halt of Celebrex Study Threatens Drug's Future, Other Trials
Couzin, J. (2004) · Science · doi:10.1126/science.306.5705.2170a · Cited by 26
Whittle, B. J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.003 · Cited by 23
Nitric oxide releasing drugs: from bench to bedside
Cirino, G. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00046-x · Cited by 21
Pathogenic role of glial cells in Parkinson's disease
Przedborski, S., & Goldman, J. E. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31043-4 · Cited by 21
Risk of hyperkalemia associated with selective COX‐2 inhibitors
Aljadhey, H. S., Tu, W., Hansen, R. A., Blalock, S. J., Brater, D. C., & Murray, M. D. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2011 · Cited by 20
Sex-dependent effect of cyclooxygenase-2 inhibition on mouse spatial memory
Guzmán, C. B., Graham, K. A., Grace, L. A., & Moore, A. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.01.005 · Cited by 14
Jonzon, B., Bjarnason, I., Hawkey, C. J., Jones, J. W., Goddard, A. F., Fagerholm, U., & Karlsson, P. (2003) · Inflammopharmacology · doi:10.1163/156856003322699618 · Cited by 11
Towards the Management of Inflammation: Recent Developments of mPGES-1 Inhibitors
Dallaporta, M., Pecchi, É., Thirion, S., Jean, A., & Troadec, J. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910789753549 · Cited by 11
Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Cited by
Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level
Gunaydin, C., & Bilge, S. S. (2019) · The Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2018.0010 · Cited by 284
Knee osteoarthritis: Current status and research progress in treatment (Review)
Geng, R., Li, J., Yu, C., Zhang, C., Chen, F., Chen, J., Ni, H., Wang, J., Kang, K., Wei, Z., et al. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12180 · Cited by 266
Astrocytes in Chronic Pain: Cellular and Molecular Mechanisms
Lu, H.-J., & Gao, Y.-J. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00961-3 · Cited by 118
Novel strategies to reverse chemoresistance in colorectal cancer
Ma, S., Zhang, J., Yan, T., Miao, M., Cao, Y., Cao, Y., Zhang, L., & Li, L. (2023) · Cancer Medicine · doi:10.1002/cam4.5594 · Cited by 108
Cofactors in Food Anaphylaxis in Adults
Bartra, J., Turner, P. J., & Muñoz-Cano, R. M. (2023) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.03.017 · Cited by 30
Metadata
- Authors
- Bacchi, S., Palumbo, P., Sponta, A., & Coppolino, M. F.
- Venue
- Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-09-01
- Volume
- 11
- Issue
- 1
- Pages
- 52-64
- ISSN
- 1568-0142 (ISSN-L)
- 1871-5230
- OpenAlex
- W2144794987
- Cited by
- 433
- References
- 148
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.